BRIEF-Health Canada approves Biopharmx's study of violet iodine

Mon Apr 4, 2016 8:53am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 4 (Reuters) - Biopharmx Corp

* Health canada approves biopharmx corporation study of violet iodine

* Engages kgk synergize, inc. To manage its canadian phase 4 study for violet molecular iodine breast health supplement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)